ライフサイエンスコーパス: cryotherapy

1 approaches have also been employed for renal cryotherapy.

2 and probable side-effects they were offered cryotherapy.

3 f the cervix with acetic acid wash (VIA) and cryotherapy.

4 One patient underwent surgical cryotherapy.

5 d with early treatment failure after salvage cryotherapy.

6 emotherapy regimens, despite the use of oral cryotherapy.

7 ed conventionally, 50 eyes were treated with cryotherapy.

8 isional biopsy, superficial keratectomy, and cryotherapy.

9 formed in 9 eyes, followed by injection site cryotherapy.

10 , laser photocoagulation, thermotherapy, and cryotherapy.

11 or for which meta-analysis was performed was cryotherapy.

12 buckle limited to the area of the holes and cryotherapy.

13 Observation, excisional biopsy, and cryotherapy.

14 chronous radiotherapy, scleral resection, or cryotherapy.

15 ia also were identified after treatment with cryotherapy.

16 ive approaches to prostate cancer, including cryotherapy.

17 5%), topical interferon alfa-2b (0% vs 1%), cryotherapy (0% vs 3%), photodynamic therapy (0% vs 1%),

18 ic therapy (0% vs 1%), excisional biopsy and cryotherapy (38% vs 65%), excisional biopsy and cryother

19 Overall, 756 women received cryotherapy, 629 (83.2%) of whom returned for their firs

20 Radiofrequency or cryotherapy ablation of AF is a relatively new treatment

21 English were found that addressed the use of cryotherapy after oral surgical procedures.

22 linical trials that assessed the benefits of cryotherapy after oral surgical procedures.

23 tomy, and in 5-9% following brachytherapy or cryotherapy after prostate cancer.

24 cation (time on/off) or extended duration of cryotherapy after surgical procedures to attain the best

25 pants, with a total of 2174 AKs treated with cryotherapy and 2170 AKs treated with PDT.

26 cases and in the presence of retinal breaks, cryotherapy and a segmental buckle limited to the retina

27 equivalent to conventional therapies such as cryotherapy and cantharidin.

28 In recent years, improvements in cryotherapy and HIFU have increased efficacy whereas dec

29 ucity of level I evidence directly comparing cryotherapy and laser treatment for threshold ROP, the l

30 all randomized trials that directly compared cryotherapy and laser.

31 e in AL and myopic shift was associated with cryotherapy and more extensive segmental buckling.

32 Cryotherapy and photocoagulation provide excellent contr

33 d cryotherapy dosage protocol led to shorter cryotherapy and procedure times, with equal safety, and

34 Of the various ablation techniques, cryotherapy and radiofrequency ablation are being increa

35 rapies, antiangiogenic agents, radiotherapy, cryotherapy and some chemotherapies.

36 complete excision with appropriate adjuvant cryotherapy and topical chemotherapy may be curative in

37 for IL Sb, 4 of 20 (20%; 95% CI, 8%-42%) for cryotherapy, and 5 of 30 (17%; 95% CI, 7%-34%) for place

38 clude observation or wide excisional biopsy, cryotherapy, and reconstruction, possibly with amniotic

39 The durability of renal cryotherapy appears promising.

40 ith respect to biochemical recurrence rates, cryotherapy appears to be as effective for low-risk pros

41 In early-stage esophageal cancer, spray cryotherapy appears to have a unique role, eliminating m

42 d improved patient selection, the results of cryotherapy are becoming more promising.

43 formal radiation therapy, brachytherapy, and cryotherapy) are gaining popularity, despite the lack of

44 vent postoperative vitreous hemorrhage using cryotherapy around sclerotomy sites and/or endolaser in

45 ults suggest that clinicians should consider cryotherapy as an alternative treatment to initial radia

46 ell carcinoma underwent local resection with cryotherapy as primary treatment.

47 s plana route with concomitant triple-freeze cryotherapy at the injection site during needle withdraw

48 The long-term biochemical outcomes following cryotherapy compare favorably to those achieved with rad

49 vitreous cell and CME for those treated with cryotherapy compared to controls were 4.73 (95% confiden

50 mes generally were seen in eyes treated with cryotherapy compared with eyes undergoing laser treatmen

51 A recent randomized trial of cryotherapy compared with radiation therapy shows simila

52 s in the New World, the combined placebo and cryotherapy cure rate (18%; 95% CI, 10%-31%) is likely t

53 at presentation, initial treatment (laser or cryotherapy), date of LSV, date of lensectomy (if perfor

54 g/mm(2) of lesion area on days 1, 3, and 5), cryotherapy (days 1 and 14), and placebo cream (daily fo

55 +/- 1.6) received a 15 minute bout of local cryotherapy, delivered via ice cup massage over the ante

56 Technical improvements in cryotherapy delivery systems have reduced the complicati

57 The new time-to-effect-based cryotherapy dosage protocol led to shorter cryotherapy a

58 e noninferiority of a novel, individualized, cryotherapy-dosing strategy for each vein.

59 The optimal dosage of cryotherapy during cryoballoon ablation of pulmonary vei

60 Cryotherapy (e.g., ice pack) is prescribed commonly afte

61 MR imaging can be used to estimate cryotherapy effects and guide therapy intraprocedurally.

62 nuous passive motion, preoperative exercise, cryotherapy, electrotherapy, and acupuncture.

63 Cryotherapy failure was defined as an increasing postcry

64 All patients received oral cryotherapy for 30 minutes with each dose of 5FU.

65 Analysis of data from the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) an

66 ere participants in the multicenter study of Cryotherapy for Retinopathy of Prematurity.

67 ze the recent literature on endoscopic spray cryotherapy for the treatment of Barrett's esophagus and

68 n clearance at 3 months after treatment than cryotherapy for thin AKs on the face and scalp.

69 Focal cryotherapy for unilateral disease offers the added bene

70 local treatments, intralesional (IL) Sb and cryotherapy, for single lesions due to Bolivian Leishman

71 Cryotherapy greatly reduces sexual function.

72 VA improved over time in the cryotherapy group (slope of -0.0018 logMAR units per mon

73 60.8 months (range 8.1-223.1 months) in the cryotherapy group and 45.0 months (range 3.1-339.0 month

74 ocular complications were identified in the cryotherapy group.

75 who had been treated using laser therapy or cryotherapy (group 1), patients with regressed ROP who h

76 edures for the treatment of prostate cancer, cryotherapy has become a feasible option as a viable alt

77 Focal cryotherapy has encouraging short-term efficacy in terms

78 Cryotherapy has undergone considerable change.

79 Technological improvements in cryotherapy have increased its use, and long-term data o

80 options for focal therapy are available with cryotherapy having the most clinical experience.

81 options for focal therapy are available with cryotherapy having the most clinical experience.

82 both eyes and who were randomized to receive cryotherapy in 1 eye.

83 Management included excisional biopsy with cryotherapy in 23 cases (72%) and observation in 9 cases

84 pillary thermotherapy (TTT) in 18 (56%), and cryotherapy in 24 (75%) eyes.

85 yobiology open up new opportunities to apply cryotherapy in combination with chemotherapy or radiothe

86 nconclusive, and the biochemical etiology of cryotherapy in human skeletal muscle remains largely unk

87 nclude the application of various lasers and cryotherapy in the vicinity of the cleft.

88 No evidence was found to indicate that cryotherapy increased the rate of color vision deficits

89 ods of aspiration with or without adjunctive cryotherapy, intracameral cautery, or photocoagulation.

90 ive factors such as resection margin, use of cryotherapy, intraoperative ultrasound, and blood loss.

91 Initial management included cryotherapy, intravitreal injection of bevacizumab, plaq

92 Salvage cryotherapy is a minimally invasive alternative to salva

93 Endoscopic spray cryotherapy is a promising ablative modality for treatme

94 Endoscopic spray cryotherapy is a relatively new ablative modality for th

95 Excision with cryotherapy is an effective treatment for the majority o

96 Cryotherapy is commonly used in the treatment of skeleta

97 Bottom Line: Oral cryotherapy is effective for the prevention of oral muco

98 However, the data to support the use of cryotherapy is inconclusive, and the biochemical etiolog

99 Whole-gland cryotherapy is ready for prime time based on favorable b

100 lter the FAF findings, including vitrectomy, cryotherapy, laser photocoagulation, or photodynamic the

101 st (83%) also received ophthalmic treatment (cryotherapy, laser photocoagulation, thermotherapy, or p

102 in the number of complications after modern cryotherapy leads to a better quality of life, which may

103 Cryotherapy may also be performed percutaneously with ma

104 Two hours after cryotherapy, muscle biopsies were obtained to analyze ch

105 on (n = 3), photodynamic therapy (n = 1), or cryotherapy (n = 1) for tumor control.

106 9%), external beam radiotherapy (n = 1, 3%), cryotherapy (n = 1, 3%), or palliative chemotherapy (n =

107 luded excisional biopsy (n = 4), followed by cryotherapy (n = 3) and/or brachytherapy (n = 3).

108 Cryotherapy of fibroadenomas is a safe, effective, and v

109 Surgical resection or cryotherapy of hepatic metastasis from colorectal cancer

110 MR imaging-guided percutaneous cryotherapy of liver tumors is feasible and safe.

111 MR imaging-guided percutaneous cryotherapy of renal tumors shows promise for the treatm

112 Current salvage cryotherapy of the prostate can result in undetectable s

113 Cryotherapy of the prostate represents a potential treat

114 The Cryotherapy On-Line Data Registry (COLD Registry) used t

115 focal therapy (TFT) using the modalities of cryotherapy or high intensity focused ultrasound as an a

116 gas into the vitreous cavity, combined with cryotherapy or laser retinopexy and followed by postoper

117 Excisional biopsy, cryotherapy, oral cimetidine, topical or injection inter

118 Cryotherapy, plaque radiotherapy, external beam radiothe

119 ts receiving treatment for cancer, does oral cryotherapy prevent oral mucositis?

120 Cryotherapy procedures declined across all indications.

121 A clinically relevant dose of cryotherapy produced negligible acute biochemical and mo

122 ses indicate that the Cambridge prophylactic cryotherapy protocol is safe and markedly reduces the ri

123 y and efficacy of the Cambridge prophylactic cryotherapy protocol, a standardized retinal prophylacti

124 Spray cryotherapy rapidly cools tissues by spraying them with

125 Cryotherapy reduced levels of hexose sugars and hypoxant

126 cold therapy, and two studies indicated that cryotherapy reduced post-surgical edema and pain.

127 MR imaging-guided percutaneous cryotherapy resulted in no serious complications and no

128 Physiological studies indicated cryotherapy resulted in vasoconstriction, reduction of e

129 No randomized trial evaluated brachytherapy, cryotherapy, robotic radical prostatectomy, or photon-be

130 y, rhegmatogenous retinal detachment, use of cryotherapy, scleral buckling at the time of pars plana

131 A single-visit approach with VIA and cryotherapy seems to be safe, acceptable, and feasible i

132 The subset of patients cured by salvage cryotherapy seems to be small, and patient selection is

133 seemed to be consensus among clinicians that cryotherapy should be applied for 10 to 20 minutes follo

134 Focal cryotherapy shows promising early results with potency r

135 Focal cryotherapy shows very high potency rates and warrants f

136 Treatment with adjuvant cryotherapy significantly decreased the risk of tumor re

137 ammation and achieve beneficial results with cryotherapy, skin temperature (normally 33 degrees C) ne

138 P at presentation, prior treatment (laser or cryotherapy), subsequent retinal surgeries, presence of

139 ies of the prostate appears to be higher for cryotherapy than for initial radiation therapy.

140 ere no more likely in eyes that had received cryotherapy than in control eyes.

141 Compared with cryotherapy, the pooled relative risk for the meta-analy

142 the study group had a significantly shorter cryotherapy time (28.3+/-7 versus 19.4+/-4.3 minutes; P<

143 ms have reduced the complications of primary cryotherapy to a low and acceptable level.

144 ution was conducted to compare the effect of cryotherapy to eyes with pars planitis to those receivin

145 biopsy, limited superficial keratectomy, and cryotherapy to the remaining conjunctival margins.

146 OP has evolved from later, more destructive (cryotherapy) to earlier, less destructive (LASER therapy

147 of threshold ROP and treatment with laser or cryotherapy (treated group) and those with regressed ROP

148 chamber cell, vitreous cell, and CME in the cryotherapy-treated eyes.

149 e of positive post-treatment biopsies in the cryotherapy-treated patients.

150 n up to 87-98% of patients after one or more cryotherapy treatments.

151 Very low-certainty evidence showed that cryotherapy was associated with a reduction in opioid co

152 Cryotherapy was associated with greater increase in AL (

153 Both VIA and cryotherapy were highly acceptable to the patients (over

154 All recurrences of OSSN after excision and cryotherapy were noted and categorized in relation to cl

155 reated with excisional biopsy and adjunctive cryotherapy were retrospectively reviewed.

156 rally treated with wide surgical margins and cryotherapy, whereas unexpected OSSN with pterygia was t

157 ternal beam radiotherapy, brachytherapy, and cryotherapy will be reviewed.

158 otherapy (38% vs 65%), excisional biopsy and cryotherapy with adjuvant oral cimetidine (8% vs 9%), an

159 tidine (8% vs 9%), and excisional biopsy and cryotherapy with adjuvant topical or injection interfero

160 d clinical trials was a direct comparison of cryotherapy with laser.

161 Excisional biopsy and cryotherapy with or without adjuvant oral cimetidine and

162 this review, we discuss contemporary data on cryotherapy with specific focus on studies using the new

163 determine how a clinically-relevant dose of cryotherapy would impact the transcriptome and metabolom